In head and neck squamous cell carcinoma (HNSCC), CXCL14 could be used as a functional prognosis biomarker for patients’ better overall survival rate (Li et al., 2020a; Wu et al., 2021). The gene discussed is CXCL14; the disease is head and neck squamous cell carcinoma.